WEDNESDAY, Sept. 23, 2020 (HealthDay News) — Women are more likely to experience anxiety and depression, and women and older children are more likely to receive mental health treatment, according to new statistics from four data briefs published by the U.S. Centers for Disease Control and Prevention National Center for Health Statistics.
SARS-CoV-2 Mortality Mainly Linked to Older Age, Comorbidity
WEDNESDAY, Sept. 23, 2020 (HealthDay News) — For U.S. veterans with COVID-19, mortality is mainly associated with older age, male sex, and comorbidity, according to a study published online Sept. 23 in JAMA Network Open.
Negative Pressure Does Not Cut C-Section Infection Risk in Obese
WEDNESDAY, Sept. 23, 2020 (HealthDay News) — Compared with standard wound care, prophylactic negative pressure wound therapy does not lower the risk for surgical-site infection in obese women following cesarean delivery, according to a study published in the Sept. 22/29 issue of the Journal of the American Medical Association.
Most People With SARS-CoV-2 Do Not Remain Asymptomatic
WEDNESDAY, Sept. 23, 2020 (HealthDay News) — Most people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) do not remain asymptomatic, and the secondary attack rate is lower among contacts of people with asymptomatic infection, according to a review published online Sept. 22 in PLOS Medicine.
USPSTF Finds Evidence Lacking for Vitamin D Screening
TUESDAY, Sept. 22, 2020 (HealthDay News) — The U.S. Preventive Services Task Force (USPSTF) concludes that the current evidence is inadequate to recommend screening for vitamin D deficiency in asymptomatic adults. This finding forms the basis of a draft recommendation statement published online Sept. 22 by the USPSTF.
Rates of COVID-19 Infection Higher in Blacks, Hispanics
TUESDAY, Sept. 22, 2020 (HealthDay News) — Black and Hispanic individuals are experiencing an excess burden of severe acute respiratory syndrome coronavirus 2 infection, according to a study published online Sept. 22 in PLOS Medicine.
Perrigo Asthma Inhalers Recalled Due to Clog Risk
TUESDAY, Sept. 22, 2020 (HealthDay News) — Perrigo inhalers have been recalled because they could clog and not provide patients with any or enough medication, the U.S. Food and Drug Administration says.
Rates of Recurrent MI Declined Among U.S. Women and Men